The authors discuss the obligations of clinicians offering genetic testing for identification of cancer. These obligations are roughly: to provide benefit and avoid harm (which includes ensuring adequate evaluation, identifying candidates for testing, and promoting family-based detection), respecting patient preferences, and ensuring access (to followup care).